IMR Press / JOMH / Special Issues / 1473919910109167616

Contemporary Issues Surrounding Testicular Cancer Treatment and Survivorship

Submission deadline: 15 August 2022
Special Issue Editors
Michael J. Rovito, PhD
Department of Health Sciences, College of Health Professions and Sciences, University of Central Florida, Orlando, FL, USA
Interests: Cancer survivorship; Testicular cancer; Quality of life; Men's health; Public health
Special Issue Information

Dear Colleagues,

We invite you to contribute to this special issue of the Journal of Men’s Health that focuses on contemporary issues surrounding testicular cancer (TC). The range of topics can vary across the entire spectrum from primary preventive sciences and diagnosis to treatment and palliative care.

Approximately 80% of all testicular cancer cases are found in males under the age of 45. The disease has a 95-99% five-year survival rate when discovered in earlier stages; however, these rates decrease by nearly 25% in more advanced cases. TC survivors are at an increased risk for numerous adverse health outcomes because of TC’s unique treatment. For example, TC survivors are subject to mental (e.g., post-traumatic stress disorder, depression, anxiety) and physical health concerns (e.g., hormonal imbalances, impotence, fatigue, overweight/obesity) that adversely affect their health-related quality of life from immediately post-treatment up to several years post-treatment. In fact, at least 20% of TC survivors need psychological support up to a decade after initial treatment. Needless to say, there is a growing need for further studies regarding this disease.

We welcome your contributions to this very special issue on testicular cancer. It will provide a unique opportunity to disseminate research on the following topics:

· Primordial and primary prevention strategies

· Self-examination and screening

· Diagnosis and staging

· Treatment (chemo and radiation therapies and surgery)

· Palliative care

We welcome both original studies (both qualitative and quantitative), as well as reviews and meta-analyses. Technical papers focusing on public health policy and implementation are also welcome.

Dr. Michael J. Rovito

Guest Editor

Keywords
Testicular cancer
Genitourinary sciences
Chemotherapy
Radiation therapy
Men’s health
Testicular self-examination
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top